| For: | Jeon YW, Park IJ, Kim JE, Park JH, Lim SB, Kim CW, Yoon YS, Lee JL, Yu CS, Kim JC. Evaluating the benefit of adjuvant chemotherapy in patients with ypT0–1 rectal cancer treated with preoperative chemoradiotherapy. World J Gastrointest Surg 2021; 13(9): 1000-1011 [PMID: 34621476 DOI: 10.4240/wjgs.v13.i9.1000] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v13/i9/1000.htm |
| Number | Citing Articles |
| 1 |
Sami A. Chadi, Karineh Kazazian, Paul Savage, Christine Brezden-Masley, Ron Burkes, Eric Chen, Anand Govindarajan, Ali Hosni, Raymond Jang, Erin Kennedy, John Kim, Jelena Lukovic, Aruz Mesci, Catherine O’Brien, Fayez Quereshy, Abdulazeez Salawu, Peter K. Stotland, Carol J. Swallow. A Consensus Approach to the Incorporation of Total Neoadjuvant Therapy in a Treatment Algorithm for Stage I–III Resectable Rectal Cancer. Current Oncology 2026; 33(5) doi: 10.3390/curroncol33050274
|
| 2 |
Angela Damato, Michele Ghidini, Lorenzo Dottorini, Gianluca Tomasello, Alessandro Iaculli, Antonio Ghidini, Andrea Luciani, Fausto Petrelli. Chemotherapy Duration for Various Indications in Colorectal Cancer: a Review. Current Oncology Reports 2023; 25(4) doi: 10.1007/s11912-023-01378-5
|
| 3 |
Neal Bhutiani, Oliver Peacock, George J. Chang. A practical framework for the targeted use of total neoadjuvant therapy for rectal cancer. Cancer 2022; 128(11) doi: 10.1002/cncr.34149
|